Eicosapentaenoic acid suppression of systemic inflammatory responses and inverse up-regulation of 15-deoxyΔ12,14 Prostaglandin J 2 production

British Journal of Pharmacology

Volumn 169, Issue 5, 2013, Pages 1130-1139

  Davidson, Jillian ^a   Higgs, Warren ^a   Rotondo, Dino ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

15d PGJ2; eicosapentaenoic acid; fever; interleukin 1 ; PGE2

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; POLYINOSINIC POLYCYTIDYLIC ACID; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; 15-DEOXYPROSTAGLANDIN J2; ANTIINFLAMMATORY AGENT; IMMUNOLOGIC FACTOR; PROSTAGLANDIN D2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; ENZYME IMMUNOASSAY; EXPERIMENTAL RABBIT; FEVER; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN BLOOD LEVEL; SYSTEMIC DISEASE; TREATMENT DURATION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED; RABBIT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; EICOSAPENTAENOIC ACID; FEVER; IMMUNOLOGIC FACTORS; INTERLEUKIN-1BETA; POLY I-C; PROSTAGLANDIN D2; RABBITS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879021563     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12209     Document Type: Article

References (54)

1. Abul H, Davidson J, Milton AS, Rotondo D, (1987). Dexamethasone pre-treatment is antipyretic toward polyinosinic: polycytidylic acid, lipopolysaccharide and interleukin 1/endogenous pyrogen. Naunyn Schmiedebergs Arch Pharmacol 335: 305-309.
2. Ackman RG, Ratnayake WMN, Olsson B, (1988). The basic fatty-acid composition of Atlantic fish oils-potential similarities useful for enrichment of poly-unsaturated fatty-acids by urea complexation. J Am Oil Chem Soc 65: 136-138.
3. Alexander SP, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
4. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, et al. (2005). Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201: 713-722.
5. Blanco M, Moro MA, Davalos A, Leira R, Castellanos M, Serena J, et al. (2005). Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. Stroke 36: 1189-1194.
6. Bonner SA, Rotondo D, Davidson J, (1997). Eicosapentaenoic acid supplementation modulates the immune responsiveness of human blood. Prostaglandins Leukot Essent Fatty Acids 57: 244-244.
7. Buydens-Branchey L, Branchey M, Hibbeln JR, (2011). Higher n-3 fatty acids are associated with more intense fenfluramine-induced ACTH and cortisol responses among cocaine-abusing men. Psychiatry Res 188: 422-427.
8. Cooper AL, Rothwell NJ, (1993). Inhibition of the thermogenic and pyrogenic responses to interleukin-1 beta in the rat by dietary N-3 fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 49: 615-626.
9. Davidson J, Milton AS, Rotondo D, (1990). A study of the pyrogenic actions of interleukin-1 alpha and interleukin-1 beta: interactions with a steroidal and a non-steroidal anti-inflammatory agent. Br J Pharmacol 100: 542-546.
10. Davidson J, Flower RJ, Milton AS, Peers SH, Rotondo D, (1991). Antipyretic actions of human recombinant lipocortin-1. Br J Pharmacol 102: 7-9.
11. Davidson J, Milton AS, Rotondo D, (1992). Alpha-melanocyte-stimulating hormone suppresses fever and increases in plasma levels of prostaglandin E2 in the rabbit. J Physiol 451: 491-502.
12. Davidson J, Bonner SA, Rotondo D, (1997). Eicosapentaenoic acid supplementation attenuates the production of pro-inflammatory cytokines in human blood. Br J Pharmacol 122 S: 355-355.
13. Davidson J, Abul HT, Milton AS, Rotondo D, (2001). Cytokines and cytokine inducers stimulate prostaglandin E2 entry into the brain. Pflugers Arch 442: 526-533.
14. Davidson J, Wulfert E, Rotondo D, (2008). 7beta-hydroxy-epiandrosterone modulation of 15-deoxy-delta12,14-prostaglandin J2, prostaglandin D2 and prostaglandin E2 production from human mononuclear cells. J Steroid Biochem Mol Biol 112: 220-227.
15. Davidson J, Rotondo D, Rizzo M, Leaver H, (2012). Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolism. Br J Pharmacol 166: 1193-1210.
16. De Caterina R, Liao JK, Libby P, (2000). Fatty acid modulation of endothelial activation. Am J Clin Nutr 71: 213S-223S.
17. Dooper MM, Wassink L, M'Rabet L, Graus YM, (2002). The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype. Immunology 107: 152-159.
18. Engler MB, Engler MM, Browne A, Sun YP, Sievers R, (2000). Mechanisms of vasorelaxation induced by eicosapentaenoic acid (20:5n-3) in WKY rat aorta. Br J Pharmacol 131: 1793-1799.
19. Fischer S, von Schacky C, Schweer H, (1988). Prostaglandins E3 and F3 alpha are excreted in human urine after ingestion of n-3 polyunsaturated fatty acids. Biochim Biophys Acta 963: 501-508.
20. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM, (1995). 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812.
21. Fortier ME, Kent S, Ashdown H, Poole S, Boksa P, Luheshi GN, (2004). The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 287: R759-R766.
22. Haynes DR, Whitehouse MW, Vernon-Roberts B, (1992). The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology 76: 251-257.
23. Herlong JL, Scott TR, (2006). Positioning prostanoids of the D and J series in the immunopathogenic scheme. Immunol Lett 102: 121-131.
24. Ivanov AI, Romanovsky AA, (2004). Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front Biosci 9: 1977-1993.
25. Kearns RJ, Hayek MG, Turek JJ, Meydani M, Burr JR, Greene RJ, et al. (1999). Effect of age, breed and dietary omega-6 (n-6): omega-3 (n-3) fatty acid ratio on immune function, eicosanoid production, and lipid peroxidation in young and aged dogs. Vet Immunol Immunopathol 69: 165-183.
26. Knapp HR, (1990). Prostaglandins in human semen during fish oil ingestion: evidence for in vivo cyclooxygenase inhibition and appearance of novel trienoic compounds. Prostaglandins 39: 407-423.
27. Lands WE, (1992). Biochemistry and physiology of n-3 fatty acids. FASEB J 6: 2530-2536.
28. Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, et al. (2005). EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 67: 867-874.
29. Mackowiak PA, (2000). A symposium marking 4 milennia of antipyretic pharmacotherapy. Clin Infect Dis 31: S153-S243.
30. Malkowski MG, Thuresson ED, Lakkides KM, Rieke CJ, Micielli R, Smith WL, et al. (2001). Structure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1. J Biol Chem 276: 37547-37555.
31. Matsukura S, Kokubu F, Kurokawa M, Kawaguchi M, Ieki K, Kuga H, et al. (2006). Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells. Clin Exp Allergy 36: 1049-1062.
32. Metherel AH, Armstrong JM, Patterson AC, Stark KD, (2009). Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women. Prostaglandins Leukot Essent Fatty Acids 81: 23-29.
33. Mickleborough TD, Tecklenburg SL, Montgomery GS, Lindley MR, (2009). Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin Nutr 28: 71-77.
34. Mignot CC, Pirottin D, Farnir F, de Moffarts B, Molitor C, Lekeux P, et al. (2012). Effect of strenuous exercise and ex vivo TLR3 and TLR4 stimulation on inflammatory gene expression in equine pulmonary leukocytes. Vet Immunol Immunopathol 147: 127-135.
35. Milton AS, Wendlandt S, (1971). Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanaesthetized cats and rabbits. J Physiol 218: 325-336.
36. Milton AS, Abul HT, Davidson J, Rotondo D, (1989). Antipyretic mechanism of action of dexamethasone. In:, Lomax P, Schonbaum E, (eds). Thermoregulation: Research and Clinical Applications. Karger: Basel, pp. 74-77.
37. Mouihate A, Boisse L, Pittman QJ, (2004). A novel antipyretic action of 15-deoxy-Delta12,14-prostaglandin J2 in the rat brain. J Neurosci 24: 1312-1318.
38. Nakajima T, Kubota N, Tsutsumi T, Oguri A, Imuta H, Jo T, et al. (2009). Eicosapentaenoic acid inhibits voltage-gated sodium channels and invasiveness in prostate cancer cells. Br J Pharmacol 156: 420-431.
39. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ, (2003). NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol 284: L84-L89.
40. Pomposelli JJ, Mascioli EA, Bistrian BR, Lopes SM, Blackburn GL, (1989). Attenuation of the febrile response in guinea pigs by fish oil enriched diets. J Parenter Enteral Nutr 13: 136-140.
41. Romanovsky AA, Almeida MC, Aronoff DM, Ivanov AI, Konsman JP, Steiner AA, et al. (2005). Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front Biosci 10: 2193-2216.
42. Rotondo D, Abul HT, Milton AS, Davidson J, (1987). The pyrogenic actions of the interferon-inducer, polyinosinic:polycytidylic acid are antagonised by ketoprofen. Eur J Pharmacol 137: 257-260.
43. Rotondo D, Abul HT, Milton AS, Davidson J, (1988). Pyrogenic immunomodulators increase the level of prostaglandin E2 in the blood simultaneously with the onset of fever. Eur J Pharmacol 154: 145-152.
44. Rotondo D, Earl CR, Laing KJ, Kaimakamis D, (1994). Inhibition of cytokine-stimulated thymic lymphocyte proliferation by fatty acids: the role of eicosanoids. Biochim Biophys Acta 1223: 185-194.
45. Rubin D, Laposata M, (1992). Cellular interactions between n-6 and n-3 fatty acids: a mass analysis of fatty acid elongation/desaturation, distribution among complex lipids, and conversion to eicosanoids. J Lipid Res 33: 1431-1440.
46. Sarel I, Widmaier EP, (1995). Stimulation of steroidogenesis in cultured rat adrenocortical cells by unsaturated fatty acids. Am J Physiol 268: R1484-R1490.
47. Serhan CN, (2005). Novel omega-3-derived local mediators in anti-inflammation and resolution. Pharmacol Ther 105: 7-21.
48. Widmaier EP, Margenthaler J, Sarel I, (1995). Regulation of pituitary-adrenocortical activity by free fatty acids in vivo and in vitro. Prostaglandins Leukot Essent Fatty Acids 52: 179-183.
49. Woodman RJ, Mori TA, Burke V, Puddey IB, Barden A, Watts GF, et al. (2003). Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis 166: 85-93.
50. Xin W, Wei W, Li X, (2012a). Effect of fish oil supplementation on fasting vascular endothelial function in humans: a meta-analysis of randomized controlled trials. PLoS ONE 7: e46028.
51. Xin W, Wei W, Li X, (2012b). Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 12: 77-93.
52. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, et al. (1999). Molecular recognition of fatty acids by peroxisome proliferator- activated receptors. Mol Cell 3: 397-403.
53. Zhao Y, Joshi-Barve S, Barve S, Chen LH, (2004). Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23: 71-78.
54. Zuijdgeest-van Leeuwen SD, Dagnelie PC, Rietveld T, van den Berg JW, Wilson JH, (1999). Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions. Br J Nutr 82: 481-488.